Sodium Chloride and Contrast Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

November 29, 2019

Study Completion Date

November 29, 2019

Conditions
Kidney Failure, ChronicKidney Failure, AcuteHeart FailureDiabetes
Interventions
DRUG

Oral sodium chloride

Patients will receive capsules of sodium chloride and free water ingestion (for each capsule of sodium chloride, with 250 ml of water, assuring a minimum ingestion of 750 ml of water) in the 48 hours prior contrast injection. Patients will take capsules of sodium chloride at a dose of 100 mg/kg during 48 hours previous the injection of contrast (48, 40, 32, 24, 16, and 8 hours), at the moment of contrast injection and 12 hours after the injection of contrast.

DRUG

Intravenous sodium chloride

Patients will receive at hospital 3 ml/Kg of sodium chloride 0.9%, one hour previous contrast injection and 2 ml/kg during the 4 hours after contrast injection.

Trial Locations (1)

28034

Hospital Universitario Ramon y Cajal, Madrid

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Ministerio de Sanidad, Servicios Sociales e Igualdad

OTHER_GOV

lead

Hospital Universitario Ramon y Cajal

OTHER

NCT03476460 - Sodium Chloride and Contrast Nephropathy | Biotech Hunter | Biotech Hunter